(a) As used in this chapter, "biomarker" means a characteristic that is objectively measured and evaluated as an indicator of:
- (1) normal biological processes;
- (2) pathogenic processes; or
- (3) pharmacologic responses to a specific therapeutic intervention, including known gene-drug interactions for medications being considered for use or already being administered.
- (b) The term includes gene mutations, characteristics of genes, and protein expression.
As added by P.L.37-2024, SEC.2.